Literature DB >> 10407088

Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor.

Y Kimura1, M Ohue, T Kitaura, K Kihira.   

Abstract

An amnesic effect of anticholinergic drugs was previously described from several behavioral studies. We examined this effect induced by trihexyphenidyl and biperiden, clinically used in the parkinsonism and schizophrenic patients, by using passive avoidance tasks. Both of these drugs (0.1-10 mg/kg, s.c.) showed dose-dependent amnesic effects in the acquisition and retrieval phases. However, the effect induced by trihexyphenidyl was transient, whereas that of biperiden was long-lasting. To clarify the reason for the different duration of the amnesic activity, binding to the muscarinic receptor was examined. In the Scatchard analysis, trihexyphenidyl competed with [(3)H]quinuclidinyl benzilate ([(3)H]QNB) on the muscarinic receptor (showed increased K(d) and unchanged B(max) value), while biperiden decreased [(3)H]QNB binding (B(max) value) significantly. Furthermore, in an exchange assay for receptor inactivation, trihexyphenidyl binding to muscarinic receptors was exchanged by [(3)H]QNB completely, but biperiden decreased the exchangeable binding of [(3)H]QNB in a dose dependent manner (0.1-100 nM). These results suggested that the binding of trihexyphenidyl and biperiden to muscarinic receptor might be completely reversible and partially irreversible, respectively, whereas the K(i) values of these two drugs were similar. In conclusion, this difference in binding property may explain the difference in the time-course of the amnesic effect induced by trihexyphenidyl and biperiden. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407088     DOI: 10.1016/s0006-8993(99)01526-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Mnemonic and behavioral effects of biperiden, an M1-selective antagonist, in the rat.

Authors:  Anna Popelíková; Štěpán Bahník; Veronika Lobellová; Jan Svoboda; Aleš Stuchlík
Journal:  Psychopharmacology (Berl)       Date:  2018-04-21       Impact factor: 4.530

2.  A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.

Authors:  Inge Klinkenberg; Arjan Blokland
Journal:  Psychopharmacology (Berl)       Date:  2011-02-19       Impact factor: 4.530

3.  Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.

Authors:  Soheil Keihan Falsafi; Alev Deli; Harald Höger; Arnold Pollak; Gert Lubec
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

4.  The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders.

Authors:  Geor Bakker; Claudia Vingerhoets; Oswald J N Bloemen; Barbara J Sahakian; Jan Booij; Matthan W A Caan; Thérèse A M J van Amelsvoort
Journal:  Neuroimage Clin       Date:  2020-05-26       Impact factor: 4.881

5.  Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden.

Authors:  Elise Gieling; Welmoed Wehkamp; Remco Willigenburg; Rebecca E Nordquist; Niels-Christian Ganderup; Franz Josef van der Staay
Journal:  Behav Brain Funct       Date:  2013-01-10       Impact factor: 3.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.